Related Experiment Video
Updated: Apr 30, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
Published on: May 11, 2020
An update on the application of alternative methods for evaluating antivenom potency
Lucas Tadeu Silva1, Luiz Guilherme Dias Heneine2, Luciana Souza de Oliveira2
1Fundação Ezequiel Dias (Funed), Belo Horizonte, Brazil; Departamento de Medicina Veterinária Preventiva, Escola de Veterinária da Universidade Federal de Minas Gerais (UFMG), Brazil.
The World Health Organization promotes alternative methods for antivenom potency testing to replace animal use. While the Enzyme-Linked Immunosorbent Assay (ELISA) shows promise, validation remains a significant hurdle for these crucial alternatives.
Area of Science:
- Pharmacology and Toxicology
- Immunology
- Biotechnology
Background:
- The World Health Organization advocates for alternative methods in antivenom production, aligning with the 3Rs principle (Replacement, Reduction, and Refinement).
- Traditional in vivo lethality neutralization assays in mice are resource-intensive and raise ethical concerns.
- Alternative methods offer potential benefits in reducing time, cost, and variability associated with animal-based testing.
Purpose of the Study:
- To review and analyze existing studies on alternative methods for antivenom potency testing.
- To assess the agreement between various alternative methodologies and the established in vivo gold standard.
- To identify challenges and propose future directions for the development and implementation of alternative antivenom potency assays.
Main Methods:
- Literature review of studies comparing alternative methods with in vivo lethality neutralization assays.
- Analysis of methodologies including immunological assays and tests for venom enzymatic and toxic activity inhibition.
- Evaluation of factors influencing assay agreement, such as antibody specificity, avidity, and venom composition.
Main Results:
- The Enzyme-Linked Immunosorbent Assay (ELISA) has been the most extensively studied alternative to in vivo antivenom potency testing.
- Variability in results was observed, depending on the specific alternative method, antibody characteristics, and venom composition.
- Significant challenges exist in the validation of alternative methods, requiring substantial time and resources.
Conclusions:
- Alternative methods, particularly ELISA, show potential for replacing or reducing in vivo assays in antivenom production.
- Further development and validation efforts are necessary to overcome implementation barriers.
- Focus should be on developing and applying validated alternative methods, especially in early-stage antivenom development where regulations are less stringent.
More Related Videos
05:53A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay
Published on: December 7, 2021
12:12Identification of Hemolytic and Phospholipase Activity in Crude Extracts from Sea Anemones by Straightforward Bioassays
Published on: March 29, 2022
Related Concept Videos
Dose-Response Relationship: Potency and Efficacy
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Drug Product Performance: In Vitro–In Vivo Correlation
Pharmaceutical Poisoning: Treatment Strategies
Antimicrobial Effectiveness